🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Herb Sarnoff

Argos Therapeutics (United States)

ORCID: 0000-0002-3219-3113

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials”.

Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials

Clinical Trials(2023)10.1177/17407745231203330

N/A

0DataRank · unranked

3 citations

Steven D. Rhodes, Edina Komlódi-Pásztor, Herb Sarnoff, Vito Grasso, Meena Upadhyaya +6 more

Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1

Clinical Trials(2023)10.1177/17407745231201338

N/A

0DataRank · unranked

1 citations

Scott R. Plotkin, Nelson B. Watts, Michael J. Fisher, Laura J. Klesse, Andrés J Lessing +9 more

NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01875-z

N/A

0DataRank · unranked

9 citations

Mohamed Sherief, Maria Ioannou, Viveka Chinnasamy, Lucy Chen, Michael Frost +13 more